Skip to main content

Table 2 Prohibited concomitant drugs

From: Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trial

Canagliflozin group

 SGLT2 inhibitors other than canagliflozin

 Sulfonylureas

 Pioglitazone

Glimepiride group

 Sulfonylureas other than glimepiride

 SGLT2 inhibitors

 Pioglitazone

  1. SGLT2 sodium glucose cotransporter 2
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840